tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Aptevo Therapeutics announces new clinical data from RAINIER trial
PremiumThe FlyAptevo Therapeutics announces new clinical data from RAINIER trial
1M ago
Aptevo Therapeutics Signs Equity Purchase Agreement
Premium
Company Announcements
Aptevo Therapeutics Signs Equity Purchase Agreement
1M ago
Aptevo Therapeutics files to sell 1.71M shares of common stock, warrants
Premium
The Fly
Aptevo Therapeutics files to sell 1.71M shares of common stock, warrants
1M ago
Aptevo Therapeutics Announces Reverse Stock Split
PremiumCompany AnnouncementsAptevo Therapeutics Announces Reverse Stock Split
2M ago
Aptevo Therapeutics announces 1-for-20 reverse stock split
Premium
The Fly
Aptevo Therapeutics announces 1-for-20 reverse stock split
2M ago
Aptevo Therapeutics reports Q1 EPS ($4.39) vs. ($368.21) last year
Premium
The Fly
Aptevo Therapeutics reports Q1 EPS ($4.39) vs. ($368.21) last year
2M ago
Aptevo Therapeutics announces $2M registered direct offering
PremiumThe FlyAptevo Therapeutics announces $2M registered direct offering
3M ago
Aptevo Therapeutics prices 1.76M shares at $1.19 in registered direct offering
Premium
The Fly
Aptevo Therapeutics prices 1.76M shares at $1.19 in registered direct offering
4M ago
Aptevo Therapeutics Achieves Remission Success in AML Trial
Premium
Company Announcements
Aptevo Therapeutics Achieves Remission Success in AML Trial
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100